CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Stellate Ganglion Block for the Treatment Pain

Last updated: January 26, 2021
Project Number: RA1162-000
Product Line: Rapid Response
Research Type: Drug
Report Type: Reference List
Result type: Report

Question

  1. What is the clinical effectiveness of stellate ganglion block for the treatment of chronic or acute pain in the head, neck, or upper extremities?
  2. What are the evidence-based clinical practice guidelines regarding the use of stellate ganglion block for the treatment of chronic or acute pain in the head, neck, or upper extremities?

Key Message

Four systematic reviews, 1 randomized controlled trial, and 3 non-randomized studies were identified regarding the clinical effectiveness of stellate ganglion block for the treatment of chronic or acute pain in the head, neck, or upper extremities. No evidence-based guidelines were identified regarding the use of stellate ganglion block for the treatment of chronic or acute pain in the head, neck, or upper extremities.